Try it
General Medicine · Clinical pharmacology
Sample itemWhich adverse effect should be monitored when starting an ACE inhibitor?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Rise in serum potassium and creatinine
ACE inhibitors can reduce intraglomerular pressure and aldosterone-mediated potassium excretion, so renal function and potassium require monitoring after initiation or dose escalation, especially in renal artery disease or dehydration.
Option by option
A. Rise in serum potassium and creatinine (correct)
Correct: potassium and creatinine may rise after ACE inhibition.
B. Profound hypoglycaemia in every patient
Hypoglycaemia is not the expected universal ACE-inhibitor adverse effect.
C. Blue-grey skin pigmentation
Blue-grey pigmentation is associated with other medicines such as amiodarone.
D. Permanent hearing loss
Permanent hearing loss is not a routine ACE-inhibitor toxicity.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- Clinical pharmacologyWhat is the key danger of prescribing an NSAID to a dehydrated patient with kidney impai…
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…